Account
Inquiry
XCE Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This xce tirzepatide compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
The xce tirzepatide molecule exhibits greater affinity for GIP receptors while maintaining significant GLP-1 receptor activity. This unique dual mechanism has shown promising results in reducing hyperglycemia in research settings. The compound mimics natural GIP action at GIP receptors while providing the beneficial effects of GLP-1 activation.
Our xce tirzepatide is supplied as a high purity white powder with comprehensive analytical documentation. The product is carefully packaged to ensure stability during transport and storage. Each batch undergoes rigorous quality control testing to verify purity and composition.
For research purposes only. Not for human consumption. This product should only be handled by qualified professionals in controlled laboratory environments.
